226 results on '"Loza, Matthew J."'
Search Results
2. Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)
3. Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study.
4. Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation
5. Using an electronic diary and wristband accelerometer to detect exacerbations and activity levels in COPD: a feasibility study.
6. Serologic Biomarkers of Progression Toward Diagnosis of Rheumatoid Arthritis in Active Component Military Personnel
7. Sputum transcriptomics reveal upregulation of IL-1 receptor family members in patients with severe asthma
8. Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial
9. RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients
10. sj-pdf-1-bmi-10.1177_1177271917730306 – Supplemental material for Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation
11. Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients
12. Integrating personalized gene expression profiles into predictive disease-associated gene pools
13. Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials
14. Suppression of Serum Interferon‐γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus
15. Association between Q551R IL4R genetic variants and atopic asthma risk demonstrated by meta-analysis
16. β-Agonist enhances type 2 T-cell survival and accumulation
17. Multiple color immunofluorescence for cytokine detection at the single-cell level
18. Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study
19. Exhaled nitric oxide in prednisone-dependent asthma to identify the eosinophilic positive phenotype
20. P273 Ustekinumab and guselkumab treatment results in differences in serum IL-17A, IL-17F and CRP levels in PsA patients: a comparison from ustekinumab Phase 3 and guselkumab Phase 2 programmes
21. The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis
22. Glucocorticoid- and Protein Kinase A-Dependent Transcriptome Regulation in Airway Smooth Muscle
23. Contributors
24. Natural Killer Cells
25. Genetic and Epigenetic Inactivation of TNFRSF10C in Human Prostate Cancer
26. Interactive effects of steroids and β-agonists on accumulation of type 2 T cells
27. Stratification of asthma phenotypes by airway proteomic signatures
28. Human peripheral CD2−/lo T cells: an extrathymic population of early differentiated, developing T cells
29. Peripheral NK cell phenotypes: multiple changing of faces of an adapting, developing cell
30. Differential regulation of NK cell proliferation by type I and type II IFN
31. Linear ‘2–0–1’ lymphocyte development: hypotheses on cellular bases for immunity
32. Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease
33. Responsiveness of Serum C‐Reactive Protein, Interleukin‐17A, and Interleukin‐17F Levels to Ustekinumab in Psoriatic Arthritis: Lessons From Two Phase III, Multicenter, Double‐Blind, Placebo‐Controlled Trials
34. THU0052 USTEKINUMAB AND GUSELKUMAB TREATMENT RESULTS IN DIFFERENCES IN SERUM IL17A, IL17F AND CRP LEVELS IN PSORIATIC ARTHRITIS PATIENTS: A COMPARISON FROM USTEKINUMAB PH3 AND GUSELKUMAB PH2 PROGRAMS
35. OP0278 BIOMARKER PROFILING REVEALS NOVEL MECHANISTIC INSIGHTS INTO USTEKINUMAB THERAPEUTIC RESPONSES IN SYSTEMIC LUPUS ERYTHEMATOSUS
36. OP0118 DISCRETE PATTERNS OF CITRULLINATED PEPTIDE AUTOANTIBODY REACTIVITIES EMERGE DURING PROGRESSION FROM PRE-DISEASE STATE TO DIAGNOSIS OF RHEUMATOID ARTHRITIS
37. SAT0103 LONGITUDINAL PRE-DISEASE TO DISEASE SERUM SAMPLES IDENTIFY BIOMARKERS THAT ARE UPREGULATED PRIOR TO THE DIAGNOSIS OF RHEUMATOID ARTHRITIS
38. I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatment
39. Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial
40. 251 Type II but not type I interferon signifies clinical response to ustekinumab in patients with systemic lupus erythematosus
41. Combined Blockade of TNF-α and IL-17A Alleviates Progression of Collagen-Induced Arthritis without Causing Serious Infections in Mice
42. Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation
43. A phase 2a study of toreforant, a histamine H4 receptor antagonist, in eosinophilic asthma
44. Asthma and gender impact accumulation of T cell subtypes
45. Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells
46. Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study
47. Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma
48. U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
49. Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial
50. Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.